|
Volumn 70, Issue 2, 2008, Pages 197-198
|
Needle protective devices; where are we now?
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL EFFECTIVENESS;
COST BENEFIT ANALYSIS;
EUROPE;
HEALTH CARE COST;
HEALTH CARE FACILITY;
HEALTH CARE PERSONNEL;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LAW ENFORCEMENT;
LETTER;
NEEDLESTICK INJURY;
OCCUPATIONAL EXPOSURE;
OCCUPATIONAL HAZARD;
OCCUPATIONAL SAFETY;
PROTECTIVE EQUIPMENT;
PURCHASING;
RISK REDUCTION;
SEROCONVERSION;
UNITED KINGDOM;
UNITED STATES;
EUROPE;
HEALTH PERSONNEL;
HUMANS;
NEEDLES;
NEEDLESTICK INJURIES;
OCCUPATIONAL EXPOSURE;
OCCUPATIONAL HEALTH;
PROTECTIVE DEVICES;
SAFETY MANAGEMENT;
|
EID: 50849101635
PISSN: 01956701
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jhin.2008.06.016 Document Type: Letter |
Times cited : (3)
|
References (7)
|